Secondary Progressive MS treatment fast-tracked for FDA Approval
avatar
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

http://www.opexatherapeutics.com/?page=tovaxin&section=tovaxin

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 3 found this helpful
Reply